Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jul;106(3):717-26.
doi: 10.1111/j.1476-5381.1992.tb14400.x.

Characterization of potassium currents modulated by BRL 38227 in rat portal vein

Affiliations

Characterization of potassium currents modulated by BRL 38227 in rat portal vein

T Noack et al. Br J Pharmacol. 1992 Jul.

Abstract

1. Smooth muscle cells of the rat portal vein were dispersed by enzymatic treatment and recordings of whole-cell membrane potassium currents were made by the voltage-clamp technique. In isolated cells by use of combined voltage- and current-clamp the effect of BRL 38227 on membrane potential and ionic currents was also studied. 2. BRL 38227 (0.1 to 10 microM) induced a non-inactivating potassium current (IKCO) which developed slowly (900 s to 300 s, respectively) to its full size. These effects of BRL 38227 were reversible. 3. In addition to its K-channel opening properties, BRL 38227 (1 to 10 microM) inhibited the amplitude and changed the activation and inactivation characteristics of a slowly-inactivating, calcium influx-independent, outward potassium current (I(TO)). 4. Application of stationary fluctuation analysis to IKCO, showed a mean single channel current of 0.65 pA at -10 mV under a quasi-physiological potassium gradient. 5. In a combined voltage-clamp/current-clamp configuration, BRL 38227 (1 microM) induced a mean hyperpolarization of 22 mV. 6. The induction of IKCO by BRL 38227 and the associated hyperpolarization were suppressed by glibenclamide (1 to 10 microM) in a concentration-dependent manner. Glibenclamide (1 microM) had no effect on the inhibition of I(TO) by BRL 38227 (1 microM).

PubMed Disclaimer

References

    1. Annu Rev Biophys Bioeng. 1977;6:345-81 - PubMed
    1. Arzneimittelforschung. 1989 Jan;39(1A):120-6 - PubMed
    1. J Physiol. 1991 Jan;432:259-82 - PubMed
    1. Pflugers Arch. 1991 Aug;419(1):69-75 - PubMed
    1. J Pharmacol Exp Ther. 1990 Sep;254(3):905-13 - PubMed

Publication types

LinkOut - more resources